Systems for managing reservoir chamber pressure

Information

  • Patent Grant
  • 9839753
  • Patent Number
    9,839,753
  • Date Filed
    Friday, September 26, 2014
    9 years ago
  • Date Issued
    Tuesday, December 12, 2017
    6 years ago
Abstract
Systems for managing pressure in a fluid reservoir chamber of a fluid infusion device are provided. For example, a fluid infusion device comprises a housing having a chamber for receiving a fluid reservoir. The fluid infusion device also comprises a drive system contained within the housing. A portion of the drive system is movable for dispensing fluid from the fluid reservoir. The fluid infusion device comprises a pressure management system at least partially defined in the portion of the drive system to vent air from the chamber.
Description
TECHNICAL FIELD

Embodiments of the subject matter described herein relate generally to fluid infusion devices for delivering a medication fluid to the body of a user. More particularly, embodiments of the subject matter relate to systems for managing pressure in a fluid reservoir chamber of a fluid infusion device.


BACKGROUND

Certain diseases or conditions may be treated, according to modern medical techniques, by delivering a medication or other substance to the body of a user, either in a continuous manner or at particular times or time intervals within an overall time period. For example, diabetes is commonly treated by delivering defined amounts of insulin to the user at appropriate times. Some common modes of providing insulin therapy to a user include delivery of insulin through manually operated syringes and insulin pens. Other modern systems employ programmable fluid infusion devices (e.g., insulin pumps) to deliver controlled amounts of insulin to a user.


A fluid infusion device suitable for use as an insulin pump may be realized as an external device or an implantable device, which is surgically implanted into the body of the user. External fluid infusion devices include devices designed for use in a generally stationary location (for example, in a hospital or clinic), and devices configured for ambulatory or portable use (to be carried by a user). External fluid infusion devices may establish a fluid flow path from a fluid reservoir to the patient via, for example, a suitable hollow tubing. Generally, in order to advance fluid from the fluid reservoir, a pressure is applied to the fluid to direct the fluid out of the reservoir and through the hollow tubing.


Accordingly, it is desirable to provide systems for managing pressure in a fluid reservoir chamber of a fluid infusion device. Furthermore, other desirable features and characteristics will become apparent from the subsequent detailed description and the appended claims, taken in conjunction with the accompanying drawings and the foregoing technical field and background.


BRIEF SUMMARY

In one embodiment, a fluid infusion device is provided. The fluid infusion device comprises a housing having a chamber for receiving a fluid reservoir. The fluid infusion device also comprises a drive system contained within the housing. A portion of the drive system is movable for dispensing fluid from the fluid reservoir. The fluid infusion device comprises a pressure management system at least partially defined in the portion of the drive system to vent air from the chamber.


According to one embodiment, a fluid infusion device is also provided. The fluid infusion device comprises a housing having a chamber and a fluid reservoir contained within the chamber of the housing. The fluid infusion device also comprises a connector body coupled to the housing and the fluid reservoir to define a fluid flow path out of the housing. The connector body includes one or more vents to vent air from the chamber. The fluid infusion device comprises a drive system contained within the housing and coupled to the fluid reservoir. The drive system includes a slide movable relative to the fluid reservoir to dispense fluid from the fluid reservoir. The fluid infusion device further comprises a pressure management system at least partially defined in the portion of the drive system to vent air from the chamber.


This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the detailed description. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.





BRIEF DESCRIPTION OF THE DRAWINGS

A more complete understanding of the subject matter may be derived by referring to the detailed description and claims when considered in conjunction with the following figures, wherein like reference numbers refer to similar elements throughout the figures.



FIG. 1 is a perspective view of an exemplary embodiment of a fluid infusion device according to various teachings of the present disclosure;



FIG. 1A is a top view of the fluid infusion device of FIG. 1;



FIG. 2 is cross-sectional view of the fluid infusion device of FIG. 1, taken along line 2-2 of FIG. 1A;



FIG. 3 is a perspective view of a portion of a drive system of the fluid infusion device of FIG. 1 according to an exemplary embodiment;



FIG. 4 is a perspective view of a portion of a drive system of the fluid infusion device of FIG. 1 according to an exemplary embodiment;



FIG. 5 is a perspective view of a portion of a drive system of the fluid infusion device of FIG. 1 according to an exemplary embodiment;



FIG. 6 is a detail view taken from FIG. 2 of an exemplary pressure management system for use with the fluid infusion device of FIG. 1;



FIG. 7 is a detail view taken from FIG. 6 of the exemplary pressure management system for use with the fluid infusion device of FIG. 1;



FIG. 8 is a detail cross-sectional view of an exemplary connector body of the fluid infusion device of FIG. 1, taken along line 8-8 of FIG. 1A;



FIG. 9 is a schematic cross-sectional view of an exemplary pressure management system for use with the fluid infusion device of FIG. 1;



FIG. 10 is a schematic cross-sectional view of an exemplary pressure management system for use with the fluid infusion device of FIG. 1;



FIG. 11 is a schematic cross-sectional view of an exemplary pressure management system for use with the fluid infusion device of FIG. 1;



FIG. 12 is a schematic cross-sectional view of an exemplary pressure management system for use with the fluid infusion device of FIG. 1;



FIG. 13 is a schematic cross-sectional view of an exemplary pressure management system for use with the fluid infusion device of FIG. 1, in which the pressure management system is in a first position;



FIG. 14 is a schematic cross-sectional view of an exemplary pressure management system for use with the fluid infusion device of FIG. 1, in which the pressure management system is in a second position;



FIG. 15 is a schematic cross-sectional view of an exemplary pressure management system for use with the fluid infusion device of FIG. 1, in which the pressure management system is in a first position;



FIG. 16 is a schematic cross-sectional view of an exemplary pressure management system for use with the fluid infusion device of FIG. 1, in which the pressure management system is in a second position;



FIG. 17 is a schematic cross-sectional view of an exemplary pressure management system for use with the fluid infusion device of FIG. 1, in which the pressure management system is in a first position; and



FIG. 18 is a schematic cross-sectional view of an exemplary pressure management system for use with the fluid infusion device of FIG. 1, in which the pressure management system is in a second position.





DETAILED DESCRIPTION

The following detailed description is merely illustrative in nature and is not intended to limit the embodiments of the subject matter or the application and uses of such embodiments. As used herein, the word “exemplary” means “serving as an example, instance, or illustration.” Any implementation described herein as exemplary is not necessarily to be construed as preferred or advantageous over other implementations. Furthermore, there is no intention to be bound by any expressed or implied theory presented in the preceding technical field, background, brief summary or the following detailed description.


Certain terminology may be used in the following description for the purpose of reference only, and thus are not intended to be limiting. For example, terms such as “top”, “bottom”, “upper”, “lower”, “above”, and “below” could be used to refer to directions in the drawings to which reference is made. Terms such as “front”, “back”, “rear”, “side”, “outboard”, and “inboard” could be used to describe the orientation and/or location of portions of the component within a consistent but arbitrary frame of reference which is made clear by reference to the text and the associated drawings describing the component under discussion. Such terminology may include the words specifically mentioned above, derivatives thereof, and words of similar import. Similarly, the terms “first”, “second”, and other such numerical terms referring to structures do not imply a sequence or order unless clearly indicated by the context.


The following description relates to a fluid infusion device of the type used to treat a medical condition of a user. The infusion device can be used for infusing fluid into the body of a user. The non-limiting examples described below relate to a medical device used to treat diabetes (more specifically, an insulin pump), although embodiments of the disclosed subject matter are not so limited. Accordingly, the infused medication fluid is insulin in certain embodiments. In alternative embodiments, however, many other fluids may be administered through infusion such as, but not limited to, disease treatments, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, anti-cancer treatments, medications, vitamins, hormones, or the like. For the sake of brevity, conventional features and characteristics related to infusion system operation, insulin pump and/or infusion set operation, fluid reservoirs, and fluid syringes may not be described in detail here. Examples of infusion pumps and/or related pump drive systems used to administer insulin and other medications may be of the type described in, but not limited to: U.S. Patent Publication Nos. 2009/0299290 and 2008/0269687; U.S. Pat. Nos. 4,562,751; 4,678,408; 4,685,903; 5,080,653; 5,505,709; 5,097,122; 6,485,465; 6,554,798; 6,558,351; 6,659,980; 6,752,787; 6,817,990; 6,932,584; 7,621,893; 7,828,764; and 7,905,868; which are each incorporated by reference herein.



FIG. 1 is a perspective view of an exemplary embodiment of a fluid infusion device 100, and FIG. 1A is a top view of the fluid infusion device 100. The fluid infusion device 100 is designed to be carried or worn by the patient. The fluid infusion device 100 may leverage a number of conventional features, components, elements, and characteristics of existing fluid infusion devices. For example, the fluid infusion device 100 may incorporate some of the features, components, elements, and/or characteristics described in U.S. Pat. Nos. 6,485,465 and 7,621,893, the relevant content of which is incorporated by reference herein.


With reference to FIG. 1, the fluid infusion device 100 includes a user interface 102 and a display 104 coupled to a housing 106. The user interface 102 includes one or more user input devices, such as buttons, which can be activated by the user. The user interface 102 can be used to administer a bolus of insulin, to change therapy settings, to change user preferences, to select display features, and the like. Although not required, the illustrated embodiment of the fluid infusion device 100 includes the display 104. The display 104 can be used to present various types of information or data to the user, such as, without limitation: the current glucose level of the patient; the time; a graph or chart of the patient's glucose level versus time; device status indicators; etc. In some embodiments, the display 104 is realized as a touch screen display element and, therefore, the display 104 also serves as a user interface component.


With reference to FIG. 2, the housing 106 of the fluid infusion device 100 accommodates a power supply 110, a controller 112, a drive system 114, a seal 116, a fluid reservoir system 118 and a secondary pressure management system 120. Generally, the power supply 110, the controller 112, the drive system 114 and the seal 116 are accommodated in a pump chamber 106a defined by the housing 106, and the fluid reservoir system 118 is accommodated in a reservoir chamber 106b defined by the housing 106. As will be discussed in greater detail herein, the pressure management system 120 enables air from within the reservoir chamber 106b to be vented into the pump chamber 106a of the housing 106. By venting the air within the reservoir chamber 106b into the pump chamber 106a of the housing 106, the pressure increases within the reservoir chamber 106b can be minimized, as will be discussed.


The power supply 110 is any suitable device for supplying the fluid infusion device 100 with power, including, but not limited to, a battery. In one example, the power supply 110 can be removable relative to the housing 106, however, the power supply 110 can be fixed within the housing 106. The controller 112 is in communication with the user interface 102, display 104, power supply 110 and drive system 114. The controller 112 controls the operation of the fluid infusion device 100 based on patient specific operating parameters. For example, the controller 112 controls the supply of power from the power supply 110 to the drive system 114 to activate the drive system 114 to dispense fluid from the fluid reservoir system 118. Further detail regarding the control of the fluid infusion device 100 can be found in U.S. Pat. Nos. 6,485,465 and 7,621,893, the relevant content of which was previously incorporated herein by reference.


The drive system 114 cooperates with the fluid reservoir system 118 to dispense the fluid from the fluid reservoir system 118. In one example, the drive system 114 includes a motor 122, a gear box 124, a drive screw 126 and a slide 128. The motor 122 receives power from the power supply 110. In one example, the motor 122 is an electric motor. The motor 122 includes an output shaft 130, which is coupled to the gear box 124. In one embodiment, the gear box 124 is a reduction gear box. The gear box 124 includes an output shaft 132, which is coupled to the drive screw 126.


The drive screw 126 includes a generally cylindrical distal portion 134 and a generally cylindrical proximal portion 136. The distal portion 134 has a diameter, which can be larger than a diameter of the proximal portion 136. The distal portion 134 includes a plurality of threads 138. The threads 138 are generally formed about an exterior circumference of the distal portion 134. The proximal portion 136 is generally unthreaded, and can be sized to be received within a portion of the slide 128. Thus, the proximal portion 136 can serve to align the drive screw 126 within the slide 128 during assembly, for example.


With continued reference to FIG. 2, the slide 128 is substantially cylindrical and includes a distal slide end 140, a proximal slide end 142 and a plurality of threads 144. The distal slide end 140 is adjacent to the motor 122 when the slide 128 is in a first, fully retracted position and the proximal slide end 142 is adjacent to the drive screw 126 when the slide 128 is in the first, fully retracted position. The proximal slide end 142 includes a projection 146 and a shoulder 147, which cooperate with the fluid reservoir system 118 to dispense the fluid from the fluid reservoir system 118. In one example, the projection 146 can have a diameter that is smaller than a diameter of a remainder of the slide 128. It should be noted that the use of the projection 146 is merely exemplary, as the slide 128 need not include a projection 146 such that the proximal slide end 142 can be flat or planar. The shoulder 147 is defined adjacent to the projection 146 and contacts a portion of the fluid reservoir system 118 to dispense fluid from the fluid reservoir system 118, as will be discussed in greater detail herein.


The plurality of threads 144 of the slide 128 are formed along an interior surface 128a of the slide 128 between the distal slide end 140 and the proximal slide end 142. Generally, the threads 144 do not extend into the projection 146 of the proximal slide end 142. The threads 144 are formed so as to threadably engage the threads 138 of the drive screw 126. Thus, the rotation of the drive screw 126 causes the linear translation of the slide 128.


In this regard, the slide 128 is generally sized such that in a first, retracted position, the motor 122, the gear box 124 and the drive screw 126 are substantially surrounded by the slide 128. The slide 128 is movable to a second, fully extended position through the operation of the motor 122. The slide 128 is also movable to a plurality of positions between the first, retracted position and the second, fully extended position via the operation of the motor 122. Generally, the operation of the motor 122 rotates the output shaft 130, which is coupled to the gear box 124. The gear box 124 reduces the torque output by the motor 122, and the output shaft 132 of the gear box 124 rotates the drive screw 126, which moves along the threads 144 formed within the slide 128. The movement or rotation of the drive screw 126 relative to the slide 128 causes the movement or linear translation of the slide 128 within the housing 106. The advancement of the slide 128 into a portion of the fluid reservoir system 118 causes the fluid reservoir system 118 to dispense fluid.


With reference to FIG. 3, the slide 128 also includes one or more air conduits 148, which are defined along an exterior surface 128b of the slide 128. Generally, the air conduits 148 are defined so as to be spaced apart along the exterior surface 128b from the distal slide end 140 to the proximal slide end 142 and to be spaced apart about a perimeter or circumference of the slide 128. Thus, the air conduits 148 generally extend along a longitudinal axis L of the slide 128. In the example of FIG. 3, the air conduits 148 comprise cylindrical depressions or dimples defined in the exterior surface 128b, however, the air conduits 148 can have any desired shape that facilitates air flow out of the fluid reservoir system 118 as will be discussed in greater detail herein. It should also be noted that although the air conduits 148 are illustrated herein as comprising discrete dimples defined in the exterior surface 128b, the air conduits 148 may be defined about the circumference of the slide 128 if desired. Further, while eight air conduits 148 are illustrated herein, it should be noted that the slide 128 can include any number of air conduits 148, including a single air conduit 148. In addition, it should be noted that the spacing and location of the air conduits 148 on the exterior surface 128b is merely exemplary, as the air conduits 148 may be defined in the exterior surface 128b at any desired location.


In one example, with reference to FIG. 4, the slide 128 includes one or more air conduits 148a, which are defined along an exterior surface 128b of the slide 128. In this example, the air conduits 148a are defined as horizontal slots having a greatest width in a direction perpendicular to the longitudinal axis L. The air conduits 148a are spaced apart along the exterior surface 128b of the slide 128 from the distal slide end 140 to the proximal slide end 142. It should also be noted that although the air conduits 148a are illustrated herein as comprising discrete slots defined in the exterior surface 128b, the air conduits 148a may be defined about the circumference of the slide 128 if desired. In addition, while eight air conduits 148a are illustrated herein, it should be noted that the slide 128 can include any number of air conduits 148a, including a single air conduit 148a. Further, it should be noted that the spacing and location of the air conduits 148a on the exterior surface 128b is merely exemplary, as the air conduits 148a may be defined in the exterior surface 128b at any desired location.


In one example, with reference to FIG. 5, the slide 128 includes one or more air conduits 148b, which are defined along an exterior surface 128b of the slide 128. In this example, the air conduits 148b are defined as vertical slots having a greatest width in a direction parallel to the longitudinal axis L. The air conduits 148b are spaced apart along the exterior surface 128b of the slide 128 from the distal slide end 140 to the proximal slide end 142. It should also be noted that although the air conduits 148b are illustrated herein as comprising discrete slots defined in the exterior surface 128b, the air conduits 148b may be defined about the circumference of the slide 128 if desired. In addition, while eight air conduits 148b are illustrated herein, it should be noted that the slide 128 can include any number of air conduits 148b, including a single air conduit 148b. Further, it should be noted that the spacing and location of the air conduits 148b on the exterior surface 128b is merely exemplary, as the air conduits 148b may be defined in the exterior surface 128b at any desired location.


With reference to FIG. 2, the seal 116 is disposed adjacent to the slide 128 and the reservoir chamber 106b. The seal 116 serves to separate the pump chamber 106a of the housing 106 from the reservoir chamber 106b to prevent the ingress of fluids to the motor 122, the gear box 124 and the drive screw 126 of the drive system 114. Generally, the seal 116 is positioned circumferentially about the slide 128 and defines an opening 150 through which the slide 128 can move. In one example, with reference to FIG. 6, the seal 116 cooperates with the slide 128 to define the pressure management system 120.


In this regard, as the slide 128 moves relative to the seal 116 and advances into the fluid reservoir system 118, one or more of the air conduits 148 are exposed to enable air from the fluid reservoir system 118 to pass through the one or more air conduits 148 into the housing 106. In other words, with reference to FIG. 7, as the opening 150 of the seal 116 is generally sized to be substantially similar to the size of the circumference of the slide 128, and the air conduits 148 are formed as recesses within the exterior surface 128b of the slide 128, a gap or passage 152 is formed between the seal 116 and the slide 128 when the air conduit 148 is adjacent to the seal 116. Thus, the cooperation between the seal 116 and the air conduits 148 of the slide 128 serves to vent air from the reservoir chamber 106b, thereby managing or reducing pressure in the fluid reservoir system 118.


With reference back to FIG. 2, the fluid reservoir system 118 is shown. The fluid reservoir system 118 includes a reservoir cap or connector body 154 and a fluid reservoir 156. The connector body 154 creates a fluid path from the fluid reservoir 156 to the body of the patient. In one exemplary embodiment, the connector body 154 is removably coupled to the housing 106, through any suitable technique, such as threads, press-fitting, etc. Generally, the connector body 154 is suitably sized and configured to accommodate the replacement of fluid reservoirs 156 (which are typically disposable) as needed. A sealing member, such as an O-ring 157 may be coupled between the connector body 154 and the reservoir chamber 106b to prevent the ingress of fluids into the reservoir chamber 106b of the housing 106.


In one example, the connector body 154 accommodates the fluid path from the fluid reservoir 156 to a tube 158. The tube 158 represents the fluid flow path that couples the fluid reservoir 156 to an infusion unit that couples the tube 158 to the patient (not shown). In one example, the tube 158 is coupled to the fluid reservoir 156 via a connector needle 160, which is coupled to the connector body 154 and pierces a septum 162 associated with the fluid reservoir 156. It should be noted, however, that any suitable technique could be employed to create a fluid path from the fluid reservoir 156 to the patient, and thus, this embodiment is merely exemplary.


With reference to FIG. 8, the connector body 154 may also include one or more vents 164 and a membrane 166. The one or more vents 164 also enable air to vent out of the reservoir chamber 106b. In this example, the one or more vents 164 enable air to vent into the environment. The one or more vents 164 act as a primary pressure management system for the fluid infusion device 100, and thus, the one or more vents 164 and the pressure management system 120 cooperate to manage pressure within the reservoir chamber 106b. The membrane 166 is generally a hydrophobic membrane, and allows air to pass through the vents 164 while preventing the ingress of fluids, such as water, into the fluid reservoir system 118.


With reference back to FIG. 2, the fluid reservoir 156 includes a body or barrel 170 and a stopper 172. The barrel 170 has a first or distal barrel end 174 and a second or proximal barrel end 176. Fluid F is retained within the barrel 170 between the distal barrel end 174 and the proximal barrel end 176. The distal barrel end 174 is positioned adjacent to the slide 128 when the fluid reservoir 156 is assembled in the housing 106. Generally, the distal barrel end 174 can have an open perimeter or can be circumferentially open such that the slide 128 is receivable within the barrel 170 through the distal barrel end 174. The proximal barrel end 176 defines a port 176a, which receives the connector needle 160 to define the fluid path. The proximal barrel end 176 can have any desirable size and shape configured to mate with at least a portion of the connector body 154.


The stopper 172 is disposed within the barrel 170. The stopper 172 is movable within and relative to the barrel 170 to dispense fluid from the fluid reservoir 156. When the barrel 170 is full of fluid, the stopper 172 is adjacent to the distal barrel end 174, and the stopper 172 is movable to a position adjacent to the proximal barrel end 176 to empty the fluid from the fluid reservoir 156. In one example, the stopper 172 is substantially cylindrical, and includes a distal stopper end 178, a proximal stopper end 180, at least one friction element 182 and a counterbore 184 defined from the distal stopper end 178 to the proximal stopper end 180.


The distal stopper end 178 is open about a perimeter of the distal stopper end 178, and thus, is generally circumferentially open. The proximal stopper end 180 is closed about a perimeter of the proximal stopper end 180 and is generally circumferentially closed. The proximal stopper end 180 includes a slightly conical external surface, however, the proximal stopper end 180 can be flat, convex, etc. The at least one friction element 182 is coupled to the stopper 172 about an exterior surface 172a of the stopper 172. In one example, the at least one friction element 182 comprises two friction elements, which include, but are not limited to, O-rings. The friction elements 182 are coupled to circumferential grooves 186 defined in the exterior surface 172a of the stopper 172.


The counterbore 184 receives the projection 146 of the slide 128 and the movement of the slide 128 causes the shoulder 147 of the slide 128 to contact and move the stopper 172. In one example, the counterbore 184 includes threads 188, however, the projection 146 of the slide 128 is not threadably engaged with the stopper 172. Thus, the threads 188 illustrated herein are merely exemplary.


With continued reference to FIG. 2, with the housing 106 assembled with the power supply 110, the controller 112 and the drive system 114, the fluid reservoir system 118 can be coupled to the housing 106. In one example, a full fluid reservoir 156 is inserted into the reservoir chamber 106b of the housing 106 such that the stopper 172 is adjacent to the projection 146 of the slide 128. As the drive screw 126 rotates, the slide 128 translates linearly. The advancement of the slide 128 decreases an available volume of the reservoir chamber 106b, which results in an increase in pressure in the reservoir chamber 106b.


As the pressure increases in the reservoir chamber 106b, in most instances, the pressure is relieved through the vents 164 of the connector body 154 (FIG. 8). In certain instances, for example, due to an obstruction of one or more of the vents 164, the pressure is relieved by the pressure management system 120. In this regard, as the slide 128 moves past the seal 116, the air conduits 148 enable pressure to be relieved by venting the air out of the reservoir chamber 106b into the pump chamber 106a of the housing 106 (FIG. 2). Thus, the pressure management system 120 manages the pressure within the reservoir chamber 106b by enabling the venting of air from the reservoir chamber 106b into the pump chamber 106a of the housing 106 through the air conduits 148.


With reference now to FIG. 9, a pressure management system 220 is shown. As the pressure management system 220 can be used with the fluid infusion device 100 discussed with regard to FIGS. 1-8, only the pressure management system 220 will be discussed in detail herein.


In this example, the pressure management system 220 is defined in a slide 228 for use with the fluid infusion device 100. The slide 228 is substantially cylindrical and includes the distal slide end 140, a proximal slide end 242 and the plurality of threads 144. The proximal slide end 242 includes a projection 246, which cooperates with the fluid reservoir system 118 to dispense the fluid from the fluid reservoir system 118. In one example, the projection 246 can have a diameter that is smaller than a diameter of a remainder of the slide 228.


The pressure management system 220 is defined on the projection 246 of the slide 228. In one example, the pressure management system 220 comprises one or more bores 248, which are defined in and through an uppermost surface 246a of the projection 246. The bores 248 may be defined through the uppermost surface 246a in any desired pattern, and in one example, may be defined through the uppermost surface 246a so as to be spaced apart from or inward from an outer circumference of the uppermost surface 246a. In addition, it should be noted that while three bores 248 are illustrated herein, the pressure management system 220 can include any number of bores 248. The bores 248 can have any desired size or diameter, and the size or diameter may be varied amongst the bores 248 to enable tuning of the pressure management system 220 to the desired air flow rate. Moreover, while the bores 248 are illustrated herein as being cylindrical or with a circular perimeter, the bores 248 can have any desired polygonal shape, such as triangular or pentagonal, for example. It should be noted that the use of the projection 246 is merely exemplary, as the slide 228 need not include the projection 246 such that the proximal slide end 242 can be flat or planar, with the pressure management system 220 defined through the flat or planar end. Further, while the bores 248 are illustrated and described herein as being defined in the slide 228, the bores 248 may be defined at any desirable location to enable venting of the fluid reservoir 156, for example, the bores 248 may be defined in and through the seal 116. Thus, the location of the bores 248 is merely exemplary.


As discussed above, with the slide 228 assembled within the fluid infusion device 100, in order to dispense fluid from the fluid reservoir 156, the drive screw 126 rotates and the slide 228 translates linearly to move the stopper 172 (FIG. 2). The advancement of the slide 228 and the stopper 172 within the fluid reservoir 156 increases the pressure in the reservoir chamber 106b.


As the pressure increases in the reservoir chamber 106b, in most instances, the pressure is relieved through the vents 164 of the connector body 154 (FIG. 8). In certain instances, for example, due to an obstruction or one or more of the vents 164, the pressure is relieved by the pressure management system 220. In this regard, the bores 248 formed in the uppermost surface 246a of the slide 228 enable pressure to be relieved by venting the air out of the reservoir chamber 106b into the slide 228, and out of the slide 228 into the pump chamber 106a of the housing 106. Thus, the pressure management system 220 manages the pressure within the reservoir chamber 106b by enabling the venting of air from the reservoir chamber 106b through the bores 248 and into the pump chamber 106a of the housing 106.


With reference to FIG. 10, a pressure management system 320 is shown. As the pressure management system 320 can be used with the fluid infusion device 100 discussed with regard to FIGS. 1-8, only the pressure management system 320 will be discussed in detail herein. Further, as the pressure management system 320 can be similar to the pressure management system 220 described with regard to FIG. 9, the same reference numerals will be employed to denote the same or similar components.


In this example, the pressure management system 320 is defined in a slide 328 for use with the fluid infusion device 100. The slide 328 is substantially cylindrical and includes the distal slide end 140, a proximal slide end 342 and the plurality of threads 144. The proximal slide end 342 includes a projection 346, which cooperates with the fluid reservoir system 118 to dispense the fluid from the fluid reservoir system 118. In one example, the projection 346 can have a diameter that is smaller than a diameter of a remainder of the slide 328.


The pressure management system 320 is defined on the projection 346 of the slide 328. In one example, the pressure management system 320 comprises one or more bores 348 and a membrane 350. In this example, the projection 346 includes an annular counterbore 352 defined in a proximalmost surface 346a. It should be noted that the use of the projection 346 is merely exemplary, as the slide 328 need not include the projection 346 such that the proximal slide end 342 can be flat or planar, with the annular counterbore 352 defined through the flat or planar end.


The bores 348 are defined in and through a surface 352a of the annular counterbore 352. The bores 348 may be defined through the surface 352a in any desired pattern, and in one example, may be defined through the surface 352a so as to be spaced apart from or inward from a perimeter or circumference of the annular counterbore 352. In addition, it should be noted that while a single bore 348 is illustrated herein, the pressure management system 320 can include any number of bores 348. The bore 348 can have any desired size or diameter, and the size or diameter may be varied to enable tuning of the pressure management system 320 to the desired air flow rate. Moreover, while the bore 348 is illustrated herein as being cylindrical or with a circular perimeter, the bore 348 can have any desired polygonal shape, such as triangular or pentagonal, for example.


The membrane 350 is coupled to the annular counterbore 352. In one example, the membrane 350 is coupled to the annular counterbore 352 so as to substantially cover the surface 352a, and thus, the one or more bores 348. The membrane 350 is coupled to the annular counterbore 352 through any suitable technique, including, but not limited to, ultrasonic welding of the membrane 350 to the surface 352a. Generally, the membrane 350 is hydrophobic, such that air may pass through the membrane, but fluid, such as water, does not.


With the slide 328 assembled within the fluid infusion device 100, in order to dispense fluid from the fluid reservoir 156, the drive screw 126 rotates, the slide 328 translates linearly. The advancement of the slide 328 decreases the volume of the reservoir chamber 106b, which may result in an increase in the pressure in the reservoir chamber 106b. As the pressure increases in the reservoir chamber 106b, in most instances, the pressure is relieved through the vents 164 of the connector body 154 (FIG. 8). In certain instances, the pressure is relieved by the pressure management system 320. In this regard, the bore 348 formed in the surface 352a of the slide 328 enables pressure to be relieved by venting the air out of the reservoir chamber 106b into the slide 328, and out of the slide 328 into the pump chamber 106a of the housing 106. The membrane 350 enables the air to pass through the bore 348, but prevents the passage of fluid, such as water, through the bore 348. Thus, the pressure management system 320 manages the pressure within the reservoir chamber 106b by enabling the venting of air from the reservoir chamber 106b through the bore 348, while preventing the ingress of fluid, such as water, through the bore 348.


With reference now to FIG. 11, a pressure management system 420 is shown. As the pressure management system 420 can be used with the fluid infusion device 100 discussed with regard to FIGS. 1-8, only the pressure management system 420 will be discussed in detail herein.


In this example, the pressure management system 420 is defined in a portion of the housing 106 of the fluid infusion device 100. For example, the pressure management system 420 is defined in a reservoir chamber 422 of the housing 106 that receives the fluid reservoir 156 of the fluid reservoir system 118 (FIG. 2). The pressure management system 420 comprises one or more bores 448, which are defined in and through a wall 422a of the reservoir chamber 422 of the housing 106. The bores 448 may be defined through the wall 422a in any desired pattern, and in one example, may be defined through the wall 422a of the reservoir chamber 422 such that a centerline C of each bore 448 is substantially parallel to a longitudinal axis L2 of the reservoir chamber 422. The bores 448 may be arranged such that the bores 448 extend along the longitudinal axis L2 of the reservoir chamber 422, however, it should be noted that this arrangement of bores 448 is merely exemplary, as the bores 448 may be arranged offset from each other. A first end 448a of each of the bores 448 is in communication with the reservoir chamber 422. An opposite, second end 448b of each of the bores 448 is in communication with the pump chamber 106a of the housing 106 to vent the air from the bores 448 into the pump chamber 106a of the housing 106.


In addition, it should be noted that while five bores 448 are illustrated herein, the pressure management system 420 can include any number of bores 448. The bores 448 can have any desired size or diameter, and the size or diameter may be varied amongst the bores 448 to enable tuning of the pressure management system 420 to the desired air flow rate. Moreover, while the bores 448 are illustrated herein as being cylindrical or with a circular perimeter, the bores 448 can have any desired polygonal shape, such as triangular or pentagonal, for example. Further, while the bores 448 are illustrated and described herein as being defined in the wall 422a, the bores 448 may be defined at any desirable location to within the reservoir chamber 422 to enable venting of the reservoir chamber 422. Thus, the location of the bores 448 is merely exemplary.


With the fluid reservoir 156 received in the reservoir chamber 422, as the drive screw 126 rotates, a slide 428 translates linearly. As the slide 428 can be substantially similar to the slide 128 but without the one or more air conduits 148, the slide 428 will not be discussed in great detail herein. The advancement of the slide 428 decreases the volume of the reservoir chamber 422, which may result in an increase in the pressure in the reservoir chamber 422. As the pressure increases in the reservoir chamber 422, in most instances, the pressure is relieved through the vents 164 of the connector body 154 (FIG. 8). In certain instances, the pressure is relieved by the pressure management system 420. In this regard, the bores 448 formed in the wall 422a of the reservoir chamber 422 of the housing 106 enable pressure to be relieved by venting the air out of the reservoir chamber 422 into the pump chamber 106a of the housing 106. Thus, the pressure management system 420 manages the pressure within the reservoir chamber 422 by enabling the venting of air from the reservoir chamber 422 through the bores 448 and into the pump chamber 106a of the housing 106.


With reference to FIG. 12, a pressure management system 520 is shown. As the pressure management system 520 can be used with the fluid infusion device 100 discussed with regard to FIGS. 1-8, only the pressure management system 520 will be discussed in detail herein. Further, as the pressure management system 520 can be similar to the pressure management system 420 described with regard to FIG. 11, the same reference numerals will be employed to denote the same or similar components.


In the example of FIG. 12, the pressure management system 520 is defined in a portion of the housing 106 of the fluid infusion device 100. For example, the pressure management system 520 is defined in the reservoir chamber 422 of the housing 106 that receives the fluid reservoir 156 of the fluid reservoir system 118 (FIG. 2). The pressure management system 520 comprises the one or more bores 448, which are defined in and through the wall 422a of the reservoir chamber 422 of the housing 106 and a membrane 522. The bores 448 are in communication with the reservoir chamber 422 and the pump chamber 106a of the housing 106. Thus, the bores 448 enable air to be vented out of the reservoir chamber 422 through the bores 448 and into the pump chamber 106a of the housing 106 external from the reservoir chamber 422.


The membrane 522 is coupled to the wall 422a of the reservoir chamber 422. In one example, the membrane 522 is coupled to the wall 422a so as to substantially cover the bores 448. Thus, the membrane 522 in this example is coupled to the wall 422a on a side of the wall substantially opposite a side of the wall in contact with the fluid reservoir 156. The membrane 522 is coupled to the wall 422a through any suitable technique, including, but not limited to, ultrasonic welding. In the example of ultrasonic welding, a weld 524 extends between the membrane 522 and the wall 422a about a perimeter of the membrane 522. Generally, the membrane 522 is hydrophobic, such that air may pass through the membrane, but fluid, such as water, does not.


With the fluid reservoir 156 received in the reservoir chamber 422, as the drive screw 126 rotates, the slide 428 translates linearly. The advancement of the slide 428 decreases the volume of the reservoir chamber 422, which may result in an increase in the pressure in the reservoir chamber 422. As the pressure increases in the reservoir chamber 422, in most instances, the pressure is relieved through the vents 164 of the connector body 154 (FIG. 8). In certain instances, the pressure is relieved by the pressure management system 520. In this regard, the bores 448 formed in the wall 422a of the reservoir chamber 422 of the housing 106 enable pressure to be relieved by venting the air out of the reservoir chamber 422, through the bores 448, and into the pump chamber 106a of the housing 106. The membrane 522 enables the air to pass through the bores 448, but prevents the passage of fluid, such as water, through the bores 448. Thus, the pressure management system 520 manages the pressure within the fluid reservoir system 118 by enabling the venting of air from the reservoir chamber 422 through the bores 448, while preventing the ingress of fluid, such as water, into the bores 448.


With reference to FIGS. 13 and 14, a pressure management system 620 is shown. As the pressure management system 620 can be used with the fluid infusion device 100 discussed with regard to FIGS. 1-8, only the pressure management system 620 will be discussed in detail herein.


In this example, the pressure management system 620 is defined in a portion of the housing 106 of the fluid infusion device 100. For example, the pressure management system 620 is defined in a reservoir chamber 622 of the housing 106 that receives the fluid reservoir 156 of the fluid reservoir system 118 (FIG. 2). The pressure management system 620 comprises an expandable member 624.


In one example, the expandable member 624 is defined as a portion of a wall 622a of the reservoir chamber 622, which has a thickness T, which is less than a thickness T2 and a thickness T3 of the remainder of the wall 622a. The reduced thickness T of the expandable member 624 enables the expandable member 624 to move or flex from a first, relaxed position (FIG. 13) to a second, expanded position (FIG. 14) to relieve pressure in the reservoir chamber 622. In other words, the expandable member 624 bulges outwardly from the remainder of the reservoir chamber 622, in a direction substantially opposite the fluid reservoir 156, to increase an available volume within the reservoir chamber 622. By increasing the available volume within the reservoir chamber 622, the pressure in the reservoir chamber 622 from the advancement of the slide 128 in the fluid reservoir 156 is reduced. Generally, the expandable member 624 extends over only a portion of the wall 622a, however, the expandable member 624 can extend over the entirety of the wall 622a, if desired. In addition, it should be noted that the expandable member 624 may be composed of the same material as a remainder of the wall 622a, or may be composed of a different, elastic material, in order to further increase the ability of the expandable member 624 to expand. Thus, the expandable member 624 illustrated herein is merely exemplary.


With the fluid reservoir 156 received in the reservoir chamber 622, as the drive screw 126 rotates, the slide 428 translates linearly. The advancement of the slide 428 decreases the volume of the reservoir chamber 622, which may result in an increase in the pressure in the reservoir chamber 622. As the pressure increases, in most instances, the pressure is relieved through the vents 164 of the connector body 154 (FIG. 8). In certain instances, the expandable member 624 moves from the first, relaxed position (FIG. 13) to the second, expanded position (FIG. 14) to increase the volume within the reservoir chamber 622 to relieve the pressure. By increasing the volume within the reservoir chamber 622, the pressure within the reservoir chamber 622 decreases. Thus, the pressure management system 620 manages the pressure within the fluid reservoir system 118 by increasing the volume within the reservoir chamber 622.


With reference to FIGS. 15 and 16, a pressure management system 720 is shown. As the pressure management system 720 can be used with the fluid infusion device 100 discussed with regard to FIGS. 1-8, only the pressure management system 720 will be discussed in detail herein.


In this example, the pressure management system 720 is coupled to a portion of the housing 106 of the fluid infusion device 100. For example, the pressure management system 720 is coupled to a reservoir chamber 722 of the housing 106 that receives the fluid reservoir 156 of the fluid reservoir system 118 (FIG. 2). The pressure management system 720 comprises one or more bores 748 and a valve 750.


The one or more bores 748 are defined in and through a wall 722a of the reservoir chamber 722. The bores 748 may be defined through the wall 722a in any desired pattern, and in one example, may be defined through the wall 722a of the reservoir chamber 722 such that a centerline of each bore 748 is substantially parallel to the longitudinal axis L2 of the reservoir chamber 722. The bores 748 may be arranged such that the bores 748 extend along the longitudinal axis L2 of the reservoir chamber 722, however, it should be noted that this arrangement of bores 748 is merely exemplary, as the bores 748 may be arranged offset from each other. In addition, it should be noted that while two bores 748 are illustrated herein, the pressure management system 720 can include any number of bores 748. The bores 748 can have any desired size or diameter, and the size or diameter may be varied amongst the bores 748 to enable tuning of the pressure management system 720 to the desired air flow rate. Moreover, while the bores 748 are illustrated herein as being cylindrical or with a circular perimeter, the bores 748 can have any desired polygonal shape, such as triangular or pentagonal, for example. Further, while the bores 748 are illustrated and described herein as being defined in the wall 722a, the bores 748 may be defined at any desirable location to within the reservoir chamber 722 to enable venting of the reservoir chamber 722. Thus, the location of the bores 748 is merely exemplary. A first end 748a of each of the bores 748 is in communication with the reservoir chamber 722 and an opposite, second end 748b of each of the bores 748 is in communication with the valve 750.


The valve 750 includes a valve seat 752, a valve stem 754 and a valve seal 756. In one example, the valve 750 comprises a check valve, but the valve 750 can comprise any suitable one-way valve, such as an umbrella valve or duckbill valve. The valve seat 752 is coupled to the wall 722a on a side of the wall 722a opposite the side of the wall 722a that contacts the fluid reservoir 156 when the fluid reservoir 156 is received in the reservoir chamber 722. The valve seat 752 may be coupled to the wall 722a through any suitable technique, such as ultrasonic welding, for example. The valve seat 752 defines one or more bores 758. Generally, the valve seat 752 defines substantially the same number of bores 758 as the number of bores 748. Thus, in this example, the valve seat 752 includes two bores 758. The bores 758 are defined in the valve seat 752 such that a centerline of a respective one of the bores 758 is coaxial with the centerline of a respective one of the bores 748 to enable communication between the bores 758 of the valve seat 752 and the bores 748. Generally, the second end 748b of each of the bores 748 is in communication with the respective one of the bores 758 to define an airflow path.


The valve stem 754 is coupled to the wall 722a. In one example, the valve stem 754 is fixedly coupled to the wall 722a such that the valve stem 754 does not interfere with or contact the fluid reservoir 156 when the fluid reservoir 156 is installed in the chamber 722. Thus, the valve stem 754 may be flush with the side of the wall 722a that contacts the fluid reservoir 156.


The valve seal 756 is coupled to the valve stem 754. The valve seal 756 is sized and shaped to seal the bores 758 of the valve seat 752. Generally, the valve seal 756 is composed of a resilient material such that the valve seal 756 is movable between a first, closed position (FIG. 15) and a second, opened position (FIG. 16) upon the pressure in the reservoir chamber 722 reaching a predefined pressure threshold. In the first, closed position, the valve seal 756 is sealing against the bores 758 and thereby blocking the airflow path created by the bores 748 and the bores 758 of the valve seat 752. In the second, opened position, the valve seal 756 is spaced apart from or deflected from the valve seat 752 such that the airflow path created by the bores 748 and bores 758 of the valve seat 752 is opened, allowing venting of air from the reservoir chamber 722 into the pump chamber 106a of the housing 106.


With the fluid reservoir 156 received in the reservoir chamber 722, as the drive screw 126 rotates, the slide 428 translates linearly. The advancement of the slide 428 decreases the volume of the reservoir chamber 722, which may result in an increase in the pressure in the reservoir chamber 722. Once the pressure reaches the predefined pressure threshold, the valve seal 756 moves from the first, closed position (FIG. 15) to the second, opened position (FIG. 16) to open the airflow path created by the bores 748 and bores 758 of the valve seat 752 to vent the reservoir chamber 722. Once the pressure in the reservoir chamber 722 drops below the predefined pressure threshold, the valve seal 756 moves from the second, opened position (FIG. 16) to the first, closed position (FIG. 15). Thus, the pressure management system 720 manages the pressure within the reservoir chamber 722 by enabling the venting of air from the reservoir chamber 722 through the bores 748 and bores 758 once the pressure in the reservoir chamber 722 reaches the predefined pressure threshold. Generally, the predefined pressure threshold is less than a static pressure necessary to move the stopper 172 within the fluid reservoir 156.


With reference to FIGS. 17 and 18, a pressure management system 820 is shown. As the pressure management system 820 can be used with the fluid infusion device 100 discussed with regard to FIGS. 1-8, only the pressure management system 820 will be discussed in detail herein.


In this example, the pressure management system 820 is coupled to a portion of the housing 106 of the fluid infusion device 100. For example, the pressure management system 820 is coupled to a chamber 822 of the housing 106 that receives the fluid reservoir 156 of the fluid reservoir system 118 (FIG. 2). The pressure management system 820 comprises one or more bores 848 and a valve 850.


The one or more bores 848 are defined in and through a wall 822a of the reservoir chamber 822. In this example, a single bore 848 is defined through the wall 822a, however, any number of bores 848 may be defined in the wall 822a in any desired pattern. The bore 848 is defined through the wall 822a of the reservoir chamber 822 such that a centerline of the bore 848 is substantially parallel to the longitudinal axis L2 of the reservoir chamber 822. The bore 848 can have any desired size or diameter, and while the bore 848 is illustrated herein as being cylindrical or with a circular perimeter, the bore 848 can have any desired polygonal shape, such as triangular or pentagonal, for example. Further, while the bore 848 is illustrated and described herein as being defined in the wall 822a, the one or more bores 848 may be defined at any desirable location to within the reservoir chamber 822 to enable venting of the reservoir chamber 822. Thus, the location of the bore 848 is merely exemplary. A first end 848a of the bore 848 is in communication with the fluid reservoir 156 when installed in the reservoir chamber 822 and an opposite, second end 848b of the bore 848 is in communication with the valve 850.


The valve 850 includes a valve seat 852, a valve stem 854 and a biasing member 856. The valve seat 852 is coupled to the wall 822a on a side of the wall 822a opposite the side of the wall 822a that contacts the fluid reservoir 156 when the fluid reservoir 156 is received in the reservoir chamber 822. The valve seat 852 may be coupled to the wall 822a through any suitable technique, such as ultrasonic welding, for example. The valve seat 852 is composed of any suitable material, and in one example, is composed of an elastomeric material. The valve seat 852 defines one or more bores 858. Generally, the valve seat 852 defines substantially the same number of bores 858 as the number of bores 848. Thus, in this example, the valve seat 852 includes one bore 858. The bore 858 is defined in the valve seat 852 such that a centerline of the bore 858 is coaxial with the centerline of the bore 848 to enable communication between the bore 858 of the valve seat 852 and the bore 848. Generally, the second end 848b of the bore 848 is in communication with the bore 858 to define an airflow path. The bore 858 is shaped to receive the valve stem 854. In one example, a first end 858a of the bore 858 has a diameter that is less than a diameter of a second end 858b of the bore 858. Thus, in this example, the bore 858 tapers from the second end 858b to the first end 858a to conform with the shape of the valve stem 854.


The valve stem 854 is received in the valve seat 852. In one example, the valve stem 854 is a spherical ball, however, the valve stem 854 can have any desired shape that cooperates with the valve seat 852. Thus, the valve stem 854 and the valve seat 852 illustrated herein are merely exemplary. The valve stem 854 is received within the valve seat 852 and is movable relative to the valve seat 852 and the wall 822a. Generally, the valve stem 854 is sized so as to extend outwardly from the valve seat 852 and the wall 822a, such that a portion of the valve stem 854 extends into the reservoir chamber 822. By extending into the reservoir chamber 822, the fluid reservoir 156 contacts the valve stem 854 upon insertion to move the valve stem 854 between a first, closed position (FIG. 17) and a second, opened position (FIG. 18). In the first, closed position, no airflow path exists between the reservoir chamber 822 and the housing 106. In the second, opened position, an airflow path exists from the reservoir chamber 822, through the bore 848, the bore 858 and into the pump chamber 106a of the housing 106.


The biasing member 856 is coupled to the valve stem 854 and the wall 822a. In one example, the biasing member 856 comprises a leaf spring, which includes a first end 860 and a second end 862. In this example, the first end 860 contacts the valve stem 854 and biases the valve stem 854 into the first, closed position. The second end 862 is fixedly mounted to the wall 822a. In this example, the second end 862 includes a bore 862a for receipt of a suitable coupling device, such as a mechanical fastener 864. It should be noted that the biasing member 856 can be coupled to the wall 822a through any suitable technique, and thus, the use of the mechanical fastener 864 is merely exemplary. Moreover, it should be noted that nay suitable biasing member could be employed to bias the valve stem 854 into the first, closed position, and thus, the use of a leaf spring is merely exemplary.


Upon insertion of the fluid reservoir 156 into the reservoir chamber 822, the fluid reservoir 156 contacts the valve stem 854 (FIG. 18). As the fluid reservoir 156 is moved into a final position in the reservoir chamber 822, the force of the insertion of the fluid reservoir 156 in the reservoir chamber 822 overcomes the force of the biasing member 856 and the valve stem 854 moves from the first, closed position (FIG. 17) to the second, opened position (FIG. 18). In the second, opened position, an airflow path between the reservoir chamber 822 and the pump chamber 106a of the housing 106 is created, thereby allowing the venting of air from the reservoir chamber 822. Once the fluid reservoir 156 is removed from the reservoir chamber 822, the biasing member 856 moves the valve stem 854 from the second, opened position to the first, closed position. Thus, the pressure management system 820 manages the pressure within the reservoir chamber 822 by enabling the venting of air from the reservoir chamber 822 through the bore 848 and bore 858 upon insertion of the fluid reservoir 156.


While at least one exemplary embodiment has been presented in the foregoing detailed description, it should be appreciated that a vast number of variations exist. It should also be appreciated that the exemplary embodiment or embodiments described herein are not intended to limit the scope, applicability, or configuration of the claimed subject matter in any way. Rather, the foregoing detailed description will provide those skilled in the art with a convenient road map for implementing the described embodiment or embodiments. It should be understood that various changes can be made in the function and arrangement of elements without departing from the scope defined by the claims, which includes known equivalents and foreseeable equivalents at the time of filing this patent application.

Claims
  • 1. A fluid infusion device, comprising: a housing having a reservoir chamber that receives a fluid reservoir and a pump chamber;a drive system contained within the pump chamber of the housing and a slide of the drive system is movable relative to the fluid reservoir for dispensing fluid from the fluid reservoir;a seal disposed between the reservoir chamber and the pump chamber that defines an opening and the slide is movable relative to the seal through the opening; anda pressure management system at least partially defined in the slide of the drive system, the pressure management system including at least one air conduit that cooperates with the opening of the seal to vent air from the reservoir chamber into the pump chamber.
  • 2. The fluid infusion device of claim 1, wherein the at least one air conduit comprises at least one dimple defined in the slide and the movement of the slide relative to the opening creates an airflow path to vent the reservoir chamber.
  • 3. The fluid infusion device of claim 2, wherein the at least one dimple comprises a plurality of dimples defined in an exterior surface of the slide so as to be spaced apart along a longitudinal axis of the slide.
  • 4. The fluid infusion device of claim 1, wherein the at least one air conduit comprises at least one slot defined in the slide and the movement of the slide relative to the opening creates an airflow path to vent air from the reservoir chamber.
  • 5. The fluid infusion device of claim 4, wherein the at least one slot comprises a plurality of slots defined in an exterior surface of the slide so as to be spaced apart along a longitudinal axis of the slide.
  • 6. The fluid infusion device of claim 1, further comprising the fluid reservoir and a connector body coupled to the housing and the fluid reservoir to define a fluid path from the housing, the connector body including one or more vents to vent air from the chamber.
  • 7. The fluid infusion device of claim 1, wherein the fluid infusion device is an insulin infusion device.
  • 8. A fluid infusion device, comprising: a housing having a reservoir chamber and a pump chamber;a fluid reservoir contained within the reservoir chamber of the housing;a connector body coupled to the housing and the fluid reservoir to define a fluid flow path out of the housing, the connector body including one or more vents to vent air from the reservoir chamber;a drive system contained within the pump chamber of the housing and coupled to the fluid reservoir, the drive system including a slide movable relative to the fluid reservoir to dispense fluid from the fluid reservoir;a seal disposed between the reservoir chamber and the pump chamber that defines an opening and the slide is movable relative to the seal through the opening; anda pressure management system at least partially defined in the slide of the drive system, the pressure management system including at least one air conduit that cooperates with the opening of the seal to vent air from the reservoir chamber into the pump chamber.
  • 9. The fluid infusion device of claim 8, wherein the at least one air conduit comprises a plurality of recesses defined in an exterior surface of the slide so as to be spaced apart along a longitudinal axis of the slide.
  • 10. The fluid infusion device of claim 8, wherein the at least one air conduit comprises a plurality of slots defined in an exterior surface of the slide so as to be spaced apart along a longitudinal axis of the slide.
  • 11. The fluid infusion device of claim 8, wherein the fluid infusion device is an insulin infusion device.
US Referenced Citations (242)
Number Name Date Kind
3631847 Hobbs, II Jan 1972 A
4000741 Binard et al. Jan 1977 A
4212738 Henne Jul 1980 A
4270532 Franetzki et al. Jun 1981 A
4282872 Franetzki et al. Aug 1981 A
4373527 Fischell Feb 1983 A
4373535 Martell Feb 1983 A
4395259 Prestele et al. Jul 1983 A
4433072 Pusineri et al. Feb 1984 A
4443218 DeCant, Jr. et al. Apr 1984 A
4494950 Fischell Jan 1985 A
4529401 Leslie Jul 1985 A
4542532 McQuilkin Sep 1985 A
4550731 Batina et al. Nov 1985 A
4559037 Franetzki et al. Dec 1985 A
4562751 Nason et al. Jan 1986 A
4671288 Gough Jun 1987 A
4678408 Nason et al. Jul 1987 A
4685903 Cable et al. Aug 1987 A
4731051 Fischell Mar 1988 A
4731726 Allen, III Mar 1988 A
4781798 Gough Nov 1988 A
4803625 Fu et al. Feb 1989 A
4809697 Causey, III et al. Mar 1989 A
4826810 Aoki May 1989 A
4871351 Feingold Oct 1989 A
4898578 Rubalcaba, Jr. Feb 1990 A
5003298 Havel Mar 1991 A
5011468 Lundquist et al. Apr 1991 A
5019974 Beckers May 1991 A
5050612 Matsumura Sep 1991 A
5078683 Sancoff et al. Jan 1992 A
5080653 Voss et al. Jan 1992 A
5097122 Colman et al. Mar 1992 A
5100380 Epstein et al. Mar 1992 A
5101814 Palti Apr 1992 A
5108819 Heller et al. Apr 1992 A
5153827 Coutre et al. Oct 1992 A
5165407 Wilson et al. Nov 1992 A
5247434 Peterson et al. Sep 1993 A
5262035 Gregg et al. Nov 1993 A
5262305 Heller et al. Nov 1993 A
5264104 Gregg et al. Nov 1993 A
5264105 Gregg et al. Nov 1993 A
5284140 Allen et al. Feb 1994 A
5299571 Mastrototaro Apr 1994 A
5307263 Brown Apr 1994 A
5317506 Coutre et al. May 1994 A
5320725 Gregg et al. Jun 1994 A
5322063 Allen et al. Jun 1994 A
5338157 Blomquist Aug 1994 A
5339821 Fujimoto Aug 1994 A
5341291 Roizen et al. Aug 1994 A
5350411 Ryan et al. Sep 1994 A
5356786 Heller et al. Oct 1994 A
5357427 Langen et al. Oct 1994 A
5368562 Blomquist et al. Nov 1994 A
5370622 Livingston et al. Dec 1994 A
5371687 Holmes, II et al. Dec 1994 A
5376070 Purvis et al. Dec 1994 A
5390671 Lord et al. Feb 1995 A
5391250 Cheney, II et al. Feb 1995 A
5403700 Heller et al. Apr 1995 A
5411647 Johnson et al. May 1995 A
5482473 Lord et al. Jan 1996 A
5485408 Blomquist Jan 1996 A
5497772 Schulman et al. Mar 1996 A
5505709 Funderburk et al. Apr 1996 A
5543326 Heller et al. Aug 1996 A
5569186 Lord et al. Oct 1996 A
5569187 Kaiser Oct 1996 A
5573506 Vasko Nov 1996 A
5582593 Hultman Dec 1996 A
5586553 Halili et al. Dec 1996 A
5593390 Castellano et al. Jan 1997 A
5593852 Heller et al. Jan 1997 A
5594638 Illiff Jan 1997 A
5609060 Dent Mar 1997 A
5626144 Tacklind et al. May 1997 A
5630710 Tune et al. May 1997 A
5643212 Coutre et al. Jul 1997 A
5660163 Schulman et al. Aug 1997 A
5660176 Iliff Aug 1997 A
5665065 Colman et al. Sep 1997 A
5665222 Heller et al. Sep 1997 A
5685844 Marttila Nov 1997 A
5687734 Dempsey et al. Nov 1997 A
5704366 Tacklind et al. Jan 1998 A
5750926 Schulman et al. May 1998 A
5754111 Garcia May 1998 A
5764159 Neftel Jun 1998 A
5772635 Dastur et al. Jun 1998 A
5779665 Mastrototaro et al. Jul 1998 A
5788669 Peterson Aug 1998 A
5791344 Schulman et al. Aug 1998 A
5800420 Gross et al. Sep 1998 A
5807336 Russo et al. Sep 1998 A
5814015 Gargano et al. Sep 1998 A
5822715 Worthington et al. Oct 1998 A
5832448 Brown Nov 1998 A
5840020 Heinonen et al. Nov 1998 A
5861018 Feierbach et al. Jan 1999 A
5868669 Iliff Feb 1999 A
5871465 Vasko Feb 1999 A
5879163 Brown et al. Mar 1999 A
5885245 Lynch et al. Mar 1999 A
5897493 Brown Apr 1999 A
5899855 Brown May 1999 A
5904708 Goedeke May 1999 A
5913310 Brown Jun 1999 A
5917346 Gord Jun 1999 A
5918603 Brown Jul 1999 A
5925021 Castellano et al. Jul 1999 A
5933136 Brown Aug 1999 A
5935099 Peterson et al. Aug 1999 A
5940801 Brown Aug 1999 A
5956501 Brown Sep 1999 A
5960403 Brown Sep 1999 A
5965380 Heller et al. Oct 1999 A
5972199 Heller et al. Oct 1999 A
5978236 Faberman et al. Nov 1999 A
5997476 Brown Dec 1999 A
5999848 Gord et al. Dec 1999 A
5999849 Gord et al. Dec 1999 A
6009339 Bentsen et al. Dec 1999 A
6032119 Brown et al. Feb 2000 A
6043437 Schulman et al. Mar 2000 A
6081736 Colvin et al. Jun 2000 A
6083710 Heller et al. Jul 2000 A
6088608 Schulman et al. Jul 2000 A
6101478 Brown Aug 2000 A
6103033 Say et al. Aug 2000 A
6119028 Schulman et al. Sep 2000 A
6120676 Heller et al. Sep 2000 A
6121009 Heller et al. Sep 2000 A
6134461 Say et al. Oct 2000 A
6143164 Heller et al. Nov 2000 A
6162611 Heller et al. Dec 2000 A
6175752 Say et al. Jan 2001 B1
6183412 Benkowski et al. Feb 2001 B1
6246992 Brown Jun 2001 B1
6259937 Schulman et al. Jul 2001 B1
6329161 Heller et al. Dec 2001 B1
6408330 DeLaHuerga Jun 2002 B1
6424847 Mastrototaro et al. Jul 2002 B1
6472122 Schulman et al. Oct 2002 B1
6484045 Holker et al. Nov 2002 B1
6484046 Say et al. Nov 2002 B1
6485465 Moberg et al. Nov 2002 B2
6503381 Gotoh et al. Jan 2003 B1
6511439 Tabata Jan 2003 B1
6514718 Heller et al. Feb 2003 B2
6544173 West et al. Apr 2003 B2
6553263 Meadows et al. Apr 2003 B1
6554798 Mann et al. Apr 2003 B1
6558320 Causey, III et al. May 2003 B1
6558351 Steil et al. May 2003 B1
6560741 Gerety et al. May 2003 B1
6565509 Say et al. May 2003 B1
6579690 Bonnecaze et al. Jun 2003 B1
6591125 Buse et al. Jul 2003 B1
6592745 Feldman et al. Jul 2003 B1
6605200 Mao et al. Aug 2003 B1
6605201 Mao et al. Aug 2003 B1
6607658 Heller et al. Aug 2003 B1
6616819 Liamos et al. Sep 2003 B1
6618934 Feldman et al. Sep 2003 B1
6623501 Heller et al. Sep 2003 B2
6641533 Causey, III et al. Nov 2003 B2
6654625 Say et al. Nov 2003 B1
6659980 Moberg et al. Dec 2003 B2
6671554 Gibson et al. Dec 2003 B2
6676816 Mao et al. Jan 2004 B2
6689265 Heller et al. Feb 2004 B2
6728576 Thompson et al. Apr 2004 B2
6733471 Ericson et al. May 2004 B1
6746582 Heller et al. Jun 2004 B2
6747556 Medema et al. Jun 2004 B2
6749740 Liamos et al. Jun 2004 B2
6752787 Causey, III et al. Jun 2004 B1
6809653 Mann et al. Oct 2004 B1
6817990 Yap et al. Nov 2004 B2
6881551 Heller et al. Apr 2005 B2
6892085 McIvor et al. May 2005 B2
6893545 Gotoh et al. May 2005 B2
6895263 Shin et al. May 2005 B2
6916159 Rush et al. Jul 2005 B2
6932584 Gray et al. Aug 2005 B2
6932894 Mao et al. Aug 2005 B2
6942518 Liamos et al. Sep 2005 B2
7153263 Carter et al. Dec 2006 B2
7153289 Vasko Dec 2006 B2
7396330 Banet et al. Jul 2008 B2
7621893 Moberg et al. Nov 2009 B2
7828764 Moberg et al. Nov 2010 B2
7905868 Moberg et al. Mar 2011 B2
20010044731 Coffman et al. Nov 2001 A1
20020013518 West et al. Jan 2002 A1
20020055857 Mault et al. May 2002 A1
20020082665 Haller et al. Jun 2002 A1
20020137997 Mastrototaro et al. Sep 2002 A1
20020161288 Shin et al. Oct 2002 A1
20030060765 Campbell et al. Mar 2003 A1
20030078560 Miller et al. Apr 2003 A1
20030088166 Say et al. May 2003 A1
20030144581 Conn et al. Jul 2003 A1
20030152823 Heller Aug 2003 A1
20030176183 Drucker et al. Sep 2003 A1
20030188427 Say et al. Oct 2003 A1
20030199744 Buse et al. Oct 2003 A1
20030208113 Mault et al. Nov 2003 A1
20030220552 Reghabi et al. Nov 2003 A1
20040061232 Shah et al. Apr 2004 A1
20040061234 Shah et al. Apr 2004 A1
20040064133 Miller et al. Apr 2004 A1
20040064156 Shah et al. Apr 2004 A1
20040073095 Causey, III et al. Apr 2004 A1
20040074785 Holker et al. Apr 2004 A1
20040093167 Braig et al. May 2004 A1
20040097796 Berman et al. May 2004 A1
20040102683 Khanuja et al. May 2004 A1
20040111017 Say et al. Jun 2004 A1
20040122353 Shahmirian et al. Jun 2004 A1
20040133166 Moberg et al. Jul 2004 A1
20040167465 Mihai et al. Aug 2004 A1
20040263354 Mann et al. Dec 2004 A1
20050038331 Silaski et al. Feb 2005 A1
20050038680 McMahon et al. Feb 2005 A1
20050154271 Rasdal et al. Jul 2005 A1
20050192557 Brauker et al. Sep 2005 A1
20050197626 Moberg Sep 2005 A1
20060229694 Schulman et al. Oct 2006 A1
20060238333 Welch et al. Oct 2006 A1
20060293571 Bao et al. Dec 2006 A1
20070088521 Shmueli et al. Apr 2007 A1
20070135866 Baker et al. Jun 2007 A1
20080132843 Sharifi Jun 2008 A1
20080154503 Wittenber et al. Jun 2008 A1
20080269687 Chong et al. Oct 2008 A1
20090081951 Erdmann et al. Mar 2009 A1
20090082635 Baldus et al. Mar 2009 A1
20090299290 Moberg Dec 2009 A1
Foreign Referenced Citations (27)
Number Date Country
4329229 Mar 1995 DE
0319268 Nov 1988 EP
0806738 Nov 1997 EP
0880936 Dec 1998 EP
1338295 Aug 2003 EP
1631036 Mar 2006 EP
2218831 Nov 1989 GB
WO 9620745 Jul 1996 WO
WO 9636389 Nov 1996 WO
WO 9637246 Nov 1996 WO
WO 9721456 Jun 1997 WO
WO 9820439 May 1998 WO
WO 9824358 Jun 1998 WO
WO 9842407 Oct 1998 WO
WO 9849659 Nov 1998 WO
WO 9859487 Dec 1998 WO
WO 9908183 Feb 1999 WO
WO 9910801 Mar 1999 WO
WO 9918532 Apr 1999 WO
WO 9922236 May 1999 WO
WO 0010628 Mar 2000 WO
WO 0019887 Apr 2000 WO
WO 0048112 Aug 2000 WO
WO 02058537 Aug 2002 WO
WO 03001329 Jan 2003 WO
WO 03094090 Nov 2003 WO
WO 2005065538 Jul 2005 WO
Non-Patent Literature Citations (92)
Entry
PCT Search Report (PCT/US02/03299), dated Oct. 31, 2002, Medtronic Minimed, Inc.
(Animas Corporation, 1999). Animas . . . bringing new life to insulin therapy.
Bode B W, et al. (1996). Reduction in Severe Hypoglycemia with Long-Term Continuous Subcutaneous Insulin Infusion in Type I Diabetes. Diabetes Care, vol. 19, No. 4, 324-327.
Boland E (1998). Teens Pumping it Up! Insulin Pump Therapy Guide for Adolescents. 2nd Edition.
Brackenridge B P (1992). Carbohydrate Gram Counting A Key to Accurate Mealtime Boluses in Intensive Diabetes Therapy. Practical Diabetology, vol. 11, No. 2, pp. 22-28.
Brackenridge, B P et al. (1995). Counting Carbohydrates How to Zero in on Good Control. MiniMed Technologies Inc.
Farkas-Hirsch R et al. (1994). Continuous Subcutaneous Insulin Infusion: A Review of the Past and Its Implementation for the Future. Diabetes Spectrum From Research to Practice, vol. 7, No. 2, pp. 80-84, 136-138.
Hirsch I B et al. (1990). Intensive Insulin Therapy for Treatment of Type I Diabetes. Diabetes Care, vol. 13, No. 12, pp. 1265-1283.
Kulkarni K et al. (1999). Carbohydrate Counting a Primer for Insulin Pump Users to Zero in on Good Control. MiniMed Inc.
Marcus A O et al. (1996). Insulin Pump Therapy Acceptable Alternative to Injection Therapy. Postgraduate Medicine, vol. 99, No. 3, pp. 125-142.
Reed J et al. (1996). Voice of the Diabetic, vol. 11, No. 3, pp. 1-38.
Skyler J S (1989). Continuous Subcutaneous Insulin Infusion [CSII] With External Devices: Current Status. Update in Drug Delivery Systems, Chapter 13, pp. 163-183. Future Publishing Company.
Skyler J S et al. (1995). The Insulin Pump Therapy Book Insights from the Experts. MiniMed•Technologies.
Strowig S M (1993). Initiation and Management of Insulin Pump Therapy. The Diabetes Educator, vol. 19, No. 1, pp. 50-60.
Walsh J, et al. (1989). Pumping Insulin: The Art of Using an Insulin Pump. Published by MiniMed•Technologies.
(Intensive Diabetes Management, 1995). Insulin Infusion Pump Therapy. pp. 66-78.
Disetronic My Choice™ D-TRON™ Insulin Pump Reference Manual. (no date).
Disetronic H-TRON® plus Quick Start Manual. (no date).
Disetronic My Choice H-TRONplus Insulin Pump Reference Manual. (no date).
Disetronic H-TRON®plus Reference Manual. (no date).
(MiniMed, 1996). The MiniMed 506. 7 pages. Retrieved on Sep. 16, 2003 from the World Wide Web: http://web.archive.org/web/19961111054527/www.minimed.com/files/506—pic.htm.
(MiniMed, 1997). MiniMed 507 Specifications. 2 pages. Retrieved on Sep. 16, 2003 from the World Wide Web: http://web.archive.org/web/19970124234841/www.minimed.com/files/mmn075.htm.
(MiniMed, 1996). FAQ: The Practical Things . . . pp. 1-4. Retrieved on Sep. 16, 2003 from the World Wide Web: http://web.archive.org/web/19961111054546/www.minimed.com/files/faq—pract.htm.
(MiniMed, 1997). Wanted: a Few Good Belt Clips! 1 page. Retrieved on Sep. 16, 2003 from the World Wide Web: http://web.archive.org/web/19970124234559/www.minimed.com/files/mmn002.htm.
(MiniMed Technologies, 1994). MiniMed 506 Insulin Pump User's Guide.
(MiniMed Technologies, 1994). MiniMed™ Dosage Calculator Initial Meal Bolus Guidelines / MiniMed™ Dosage Calculator Initial Basal Rate Guidelines Percentage Method. 4 pages.
(MiniMed, 1996). MiniMed™ 507 Insulin Pump User's Guide.
(MiniMed, 1997). MiniMed™ 507 Insulin Pump User's Guide.
(MiniMed, 1998). MiniMed 507C Insulin Pump User's Guide.
(MiniMed International, 1998). MiniMed 507C Insulin Pump for those who appreciate the difference.
(MiniMed Inc., 1999). MiniMed 508 Flipchart Guide to Insulin Pump Therapy.
(MiniMed Inc., 1999). Insulin Pump Comparison / Pump Therapy Will Change Your Life.
(MiniMed, 2000). MiniMed® 508 User's Guide.
(MiniMed Inc., 2000). MiniMed® Now [I] Can Meal Bolus Calculator / MiniMed® Now [I] Can Correction Bolus Calculator.
(MiniMed Inc., 2000). Now [I] Can MiniMed Pump Therapy.
(MiniMed Inc., 2000). Now [I] Can MiniMed Diabetes Management.
(Medtronic MiniMed, 2002). The 508 Insulin Pump A Tradition of Excellence.
(Medtronic MiniMed, 2002). Medtronic MiniMed Meal Bolus Calculator and Correction Bolus Calculator. International Version.
Abel, P., et al., “Experience with an implantable glucose sensor as a prerequiste of an artificial beta cell,” Biomed. Biochim. Acta 43 (1984) 5, pp. 577-584.
Bindra, Dilbir S., et al., “Design and in Vitro Studies of a Needle-Type Glucose Sensor for a Subcutaneous Monitoring,” American Chemistry Society, 1991, 63, pp. 1692-1696.
Boguslavsky, Leonid, et al., “Applications of redox polymers in biosensors,” Sold State Ionics 60, 1993, pp. 189-197.
Geise, Robert J., et al., “Electropolymerized 1,3-diaminobenzene for the construction of a 1,1′-dimethylferrocene mediated glucose biosensor,” Analytica Chimica Acta, 281, 1993, pp. 467-473.
Gernet, S., et al., “A Planar Glucose Enzyme Electrode,” Sensors and Actuators, 17, 1989, pp. 537-540.
Gernet, S., et al., “Fabrication and Characterization of a Planar Electromechanical Cell and its Application as a Glucose Sensor,” Sensors and Actuators, 18, 1989, pp. 59-70.
Gorton, L., et al., “Amperometric Biosensors Based on an Apparent Direct Electron Transfer Between Electrodes and Immobilized Peroxiases,” Analyst, Aug. 1991, vol. 117, pp. 1235-1241.
Gorton, L., et al., “Amperometric Glucose Sensors Based on Immobilized Glucose-Oxidizing Enymes and Chemically Modified Electrodes,” Analytica Chimica Acta, 249, 1991, pp. 43-54.
Gough, D. A., et al., “Two-Dimensional Enzyme Electrode Sensor for Glucose,” Analytical Chemistry, vol. 57, No. 5, 1985, pp. 2351-2357.
Gregg, Brian A., et al., “Cross-Linked Redox Gels Containing Glucose Oxidase for Amperometric Biosensor Applications,” Analytical Chemistry, 62, pp. 258-263.
Gregg, Brian A., et al., “Redox Polymer Films Containing Enzymes. 1. A Redox-Conducting Epoxy Cement: Synthesis, Characterization, and Electrocatalytic Oxidation of Hydroquinone,” The Journal of Physical Chemistry, vol. 95, No. 15, 1991, pp. 5970-5975.
Hashiguchi, Yasuhiro, MD, et al., “Development of a Miniaturized Glucose Monitoring System by Combining a Needle-Type Glucose Sensor With Microdialysis Sampling Method,” Diabetes Care, vol. 17, No. 5, May 1994, pp. 387-389.
Heller, Adam, “Electrical Wiring of Redox Enzymes,” Acc. Chem. Res., vol. 23, No. 5, May 1990, pp. 128-134.
Jobst, Gerhard, et al., “Thin-Film Microbiosensors for Glucose-Lactate Monitoring,” Analytical Chemistry, vol. 68, No. 18, Sep. 15, 1996, pp. 3173-3179.
Johnson, K.W., et al., “In vivo evaluation of an electroenzymatic glucose sensor implanted in subcutaneous tissue,” Biosensors & Bioelectronics, 7, 1992, pp. 709-714.
Jönsson, G., et al., “An Electromechanical Sensor for Hydrogen Peroxide Based on Peroxidase Adsorbed on a Spectrographic Graphite Electrode,” Electroanalysis, 1989, pp. 465-468.
Kanapieniene, J. J., et al., “Miniature Glucose Biosensor with Extended Linearity,” Sensors and Actuators, B. 10, 1992, pp. 37-40.
Kawamori, Ryuzo, et al., “Perfect Normalization of Excessive Glucagon Responses to Intraveneous Arginine in Human Diabetes Mellitus With the Artificial Beta-Cell,” Diabetes vol. 29, Sep. 1980, pp. 762-765.
Kimura, J., et al., “An Immobilized Enzyme Membrane Fabrication Method,” Biosensors 4, 1988, pp. 41-52.
Koudelka, M., et al., “In-vivo Behaviour of Hypodermically Implanted Microfabricated Glucose Sensors,” Biosensors & Bioelectronics 6, 1991, pp. 31-36.
Koudelka, M., et al., “Planar Amperometric Enzyme-Based Glucose Microelectrode,” Sensors & Actuators, 18, 1989, pp. 157-165.
Mastrototaro, John J., et al., “An electroenzymatic glucose sensor fabricated on a flexible substrate,” Sensors & Actuators, B. 5, 1991, pp. 139-144.
Mastrototaro, John J., et al., “An Electroenzymatic Sensor Capable of 72 Hour Continuous Monitoring of Subcutaneous Glucose,” 14th Annual International Diabetes Federation Congress, Washington D.C., Jun. 23-28, 1991.
McKean, Brian D., et al., “A Telemetry-Instrumentation System for Chronically Implanted Glucose and Oxygen Sensors,” IEEE Transactions on Biomedical Engineering, Vo. 35, No. 7, Jul. 1988, pp. 526-532.
Monroe, D., “Novel Implantable Glucose Sensors,” ACL, Dec. 1989, pp. 8-16.
Morff, Robert J., et al., “Microfabrication of Reproducible, Economical, Electroenzymatic Glucose Sensors,” Annuaal International Conference of teh IEEE Engineering in Medicine and Biology Society, Vo. 12, No. 2, 1990, pp. 483-484.
Moussy, Francis, et al., “Performance of Subcutaneously Implanted Needle-Type Glucose Sensors Employing a Novel Trilayer Coating,” Analytical Chemistry, vol. 65, No. 15, Aug. 1, 1993, pp. 2072-2077.
Nakamoto, S., et al., “A Lift-Off Method for Patterning Enzyme-Immobilized Membranes in Multi-Biosensors,” Sensors and Actuators 13, 1988, pp. 165-172.
Nishida, Kenro, et al., “Clinical applications of teh wearable artifical endocrine pancreas with the newly designed needle-type glucose sensor,” Elsevier Sciences B.V., 1994, pp. 353-358.
Nishida, Kenro, et al., “Development of a ferrocene-mediated needle-type glucose sensor covereed with newly designd biocompatible membrane, 2-methacryloyloxyethylphosphorylcholine-co-n-butyl nethacrylate,” Medical Progress Through Technology, vol. 21, 1995, pp. 91-103.
Poitout, V., et al., “A glucose monitoring system for on line estimation oin man of blood glucose concentration using a miniaturized glucose sensor implanted in the subcutaneous tissue adn a wearable control unit,” Diabetologia, vol. 36, 1991, pp. 658-663.
Reach, G., “A Method for Evaluating in vivo the Functional Characteristics of Glucose Sensors,” Biosensors 2, 1986, pp. 211-220.
Shaw, G. W., et al., “In vitro testing of a simply constructed, highly stable glucose sensor suitable for implantation in diabetic patients,” Biosensors & Bioelectronics 6, 1991, pp. 401-406.
Shichiri, M., “A Needle-Type Glucose Sensor—A Valuable Tool Not Only for a Self-Blood Glucose Monitoring but for a Wearable Artifiical Pancreas,” Life Support Systems Proceedings, XI Annual Meeting ESAO, Alpbach-Innsbruck, Austria, Sep. 1984, pp. 7-9.
Shichiri, Motoaki, et al., “An artificial endocrine pancreas—problems awaiting solution for long-term clinical applications of a glucose sensor,” Frontiers Med. Biol. Engng., 1991, vol. 3, No. 4, pp. 283-292.
Shichiri, Motoaki, et al., “Closed-Loop Glycemic Control with a Wearable Artificial Endocrine Pancreas—Variations in Daily Insulin Requirements to Glycemic Response,” Diabetes, vol. 33, Dec. 1984, pp. 1200-1202.
Shichiri, Motoaki, et al., “Glycaemic Control in a Pacreatectomized Dogs with a Wearable Artificial Endocrine Pancreas,” Diabetologia, vol. 24, 1983, pp. 179-184.
Shichiri, M., et al., “In Vivo Characteristics of Needle-Type Glucose Sensor—Measurements of Subcutaneous Glucose Concentrations in Human Volunteers,” Hormone and Metabolic Research, Supplement Series vol. No. 20, 1988, pp. 17-20.
Shichiri, M., et al., “Membrane design for extending the long-life of an implantable glucose sensor,” Diab. Nutr. Metab., vol. 2, No. 4, 1989, pp. 309-313.
Shichiri, Motoaki, et al., “Normalization of the Paradoxic Secretion of Glucagon in Diabetes Who Were Controlled by the Artificial Beta Cell,” Diabetes, vol. 28, Apr. 1979, pp. 272-275.
Shichiri, Motoaki, et al., “Telemetry Glucose Monitoring Device with Needle-Type Glucose Sensor: A useful Tool for Blood Glucose Monitoring in Diabetic Individuals,” Diabetes Care, vol. 9, No. 3, May-Jun. 1986, pp. 298-301.
Shichiri, Motoaki, et al., “Wearable Artificial Endocrine Pancreas with Needle-Type Glucose Sensor,” The Lancet, Nov. 20, 1982, pp. 1129-1131.
Shichiri, Motoaki, et al., “The Wearable Artificial Endocrine Pancreas with a Needle-Type Glucose Sensor: Perfect Glycemic Control in Ambulatory Diabetes,” Acta Paediatr Jpn 1984, vol. 26, pp. 359-370.
Shinkai, Seiji, “Molecular Recognitiion of Mono- and Di-saccharides by Phenylboronic Acids in Solvent Extraction and as a Monolayer,” J. Chem. Soc., Chem. Commun., 1991, pp. 1039-1041.
Shults, Mark C., “A Telemetry-Instrumentation System for Monitoring Multiple Subcutaneously Implanted Glucose Sensors,” IEEE Transactions on Biomedical Engineering, vol. 41, No. 10, Oct. 1994, pp. 937-942.
Sternberg, Robert, et al., “Study and Development of Multilayer Needle-type Enzyme-based Glucose Microsensors,” Biosensors, vol. 4, 1988, pp. 27-40.
Tamiya, E., et al., “Micro Glucose Sensors using Electron Mediators Immobilized on a Polypyrrole-Modified Electrode,” Sensors and Actuators, vol. 18, 1989, pp. 297-307.
Tsukagoshi, Kazuhiko, et al., “Specific Complexation with Mono- and Disaccharides that can be Detected by Circular Dichroism,” J. Org. Chem., vol. 56, 1991, pp. 4089-4091.
Urban, G., et al., “Miniaturized multi-enzyme biosensors integrated with pH sensors on flexible polymer carriers for in vivo applciations,” Biosensors & Bioelectronics, vol. 7, 1992, pp. 733-739.
Ubran, G., et al., “Miniaturized thin-film biosensors using covalently immobilized glucose oxidase,” Biosensors & Bioelectronics, vol. 6, 1991, pp. 555-562.
Velho, G., et al., “In vivo calibration of a subcutaneous glucose sensor for determination of subcutaneous glucose kinetics,” Diab. Nutr. Metab., vol. 3, 1988, pp. 227-233.
Wang, Joseph, et al., “Needle-Type Dual Microsensor for the Simultaneous Monitoring of Glucose and Insulin,” Analytical Chemistry, vol. 73, 2001, pp. 844-847.
Yamasaki, Yoshimitsu, et al., “Direct Measurement of Whole Blood Glucose by a Needle-Type Sensor,” Clinics Chimica Acta, vol. 93, 1989, pp. 93-98.
Yokoyama, K., “Integrated Biosensor for Glucose and Galactose,” Analytica Chimica Acta, vol. 218, 1989, pp. 137-142.
Related Publications (1)
Number Date Country
20160089505 A1 Mar 2016 US